Related Experiment Videos
Hypoglycemia: how little is too much for the embryo?
American Journal of Obstetrics and Gynecology
|July 1, 1987
Summary
Hypoglycemia, or low blood sugar, during early embryonic development can cause birth defects. Even short exposures to reduced glucose levels during neurulation can lead to malformations in mammalian embryos.
Area of Science:
- Developmental biology
- Reproductive medicine
- Teratology
Background:
- Neurulation is a critical stage of early mammalian development.
- Maternal metabolic health, including glucose regulation, is vital for embryonic development.
- Hypoglycemia in pregnancy poses potential risks to fetal development.
Purpose of the Study:
- To investigate the teratogenic effects of maternal hypoglycemia on mammalian embryos during neurulation.
- To determine the impact of varying glucose concentrations on embryonic growth and malformation.
- To assess the sensitivity of the neurulation period to glucose fluctuations.
Main Methods:
- Whole embryo culture of mouse embryos.
- Exposure to varying glucose concentrations (40, 60, 80, 147 mg/dl) in rat serum.
- Evaluation of embryonic malformations, growth, and survival post-culture.
- Comparison with euglycemic control conditions.
Main Results:
- Glucose levels around 50% of normal maternal concentrations were teratogenic but did not inhibit growth.
- Glucose concentrations at 30%-40% of maternal levels were lethal to the embryo.
- A 14-hour exposure to hypoglycemia during either the first or second half of the culture period induced malformations.
Conclusions:
- Maternal hypoglycemia during neurulation is teratogenic and potentially lethal to mammalian embryos.
- The timing and severity of glucose reduction influence the developmental outcome.
- Maintaining euglycemia is crucial during early pregnancy to prevent birth defects.